Primary hyperparathyroidism.
作者信息
Al-Azem Hafsah, Khan Aliya
机构信息
Department of Medicine, McMaster University, Hamilton, Ont.
出版信息
CMAJ. 2011 Jul 12;183(10):E685-9. doi: 10.1503/cmaj.090675. Epub 2011 Apr 26.
Abstract
摘要
相似文献
1
Primary hyperparathyroidism.
CMAJ. 2011 Jul 12;183(10):E685-9. doi: 10.1503/cmaj.090675. Epub 2011 Apr 26.
2
[Progress in diagnosis and therapy: Hypercalcemia due to primary hyperparathyroidism].
Nihon Naika Gakkai Zasshi. 2007 Apr 10;96(4):662-8. doi: 10.2169/naika.96.662.
3
[Primary hyperparathyroidism].
Nihon Rinsho. 2006 Jun 28;Suppl 2:5-9.
4
Primary hyperparathyroidism.
Med Clin (Barc). 2018 Mar 23;150(6):226-232. doi: 10.1016/j.medcli.2017.07.020. Epub 2017 Oct 6.
5
Primary hyperparathyroidism due to parathyroid adenoma.
Saudi Med J. 2007 Feb;28(2):305; author reply 305-6.
6
Intraoperative Parathyroid Aspiration and Parathyroid Hormone Assay During Parathyroidectomy for Primary Hyperparathyroidism.
Isr Med Assoc J. 2017 Dec;19(12):731-735.
7
[Diagnostic approach and treatment of primary hyperparathyroidism].
Ned Tijdschr Geneeskd. 2017;161:D1870.
8
[Current approach to the diagnosis and treatment of primary hyperparathyroidism].
Khirurgiia (Mosk). 2019(6):26-34. doi: 10.17116/hirurgia201906126.
9
[Primary hyperparathyroidism].
Nihon Rinsho. 2005 Oct;63 Suppl 10:325-9.
10
Hyperparathyroidism.
Lancet. 2009 Jul 11;374(9684):145-58. doi: 10.1016/S0140-6736(09)60507-9.
引用本文的文献
1
Waves of Endurance: A Pilot Study of Beta Brain Wave Signatures Linked to Immune Adaptation in Transatlantic Rowers.
Cureus. 2025 May 13;17(5):e84059. doi: 10.7759/cureus.84059. eCollection 2025 May.
2
Influencing factors of serum magnesium in CKD5 patients: A multicenter study in southern China.
Front Public Health. 2022 Dec 14;10:1047602. doi: 10.3389/fpubh.2022.1047602. eCollection 2022.
3
New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.
BMC Endocr Disord. 2020 Jan 8;20(1):5. doi: 10.1186/s12902-019-0487-8.
4
An unusual case of malignancy-related hypercalcemia.
Int J Gen Med. 2013 Dec 6;7:21-7. doi: 10.2147/IJGM.S51302. eCollection 2013.
5
The association of primary hyperparathyroidism with pancreatitis.
J Clin Gastroenterol. 2012 Sep;46(8):656-61. doi: 10.1097/MCG.0b013e31825c446c.
本文引用的文献
1
Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
J Clin Endocrinol Metab. 2009 Feb;94(2):373-81. doi: 10.1210/jc.2008-1762.
2
Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
J Clin Endocrinol Metab. 2009 Feb;94(2):366-72. doi: 10.1210/jc.2008-1761.
3
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
J Clin Endocrinol Metab. 2009 Feb;94(2):351-65. doi: 10.1210/jc.2008-1760.
4
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.
J Clin Endocrinol Metab. 2009 Feb;94(2):340-50. doi: 10.1210/jc.2008-1758.
5
Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.
J Clin Endocrinol Metab. 2009 Feb;94(2):335-9. doi: 10.1210/jc.2008-1763.
6
The diagnosis and management of asymptomatic primary hyperparathyroidism revisited.
J Clin Endocrinol Metab. 2009 Feb;94(2):333-4. doi: 10.1210/jc.2008-1757.
7
Clinical review: Rare causes of hypercalcemia.
J Clin Endocrinol Metab. 2005 Nov;90(11):6316-22. doi: 10.1210/jc.2005-0675. Epub 2005 Aug 30.
8
Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
J Clin Endocrinol Metab. 2005 Apr;90(4):2122-6. doi: 10.1210/jc.2004-1772. Epub 2005 Jan 11.
9
Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
J Clin Endocrinol Metab. 2004 Jul;89(7):3319-25. doi: 10.1210/jc.2003-030908.
10
Asymptomatic primary hyperparathyroidism: standards and guidelines for diagnosis and management in Canada: Consensus Development Task Force on Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism position paper.
Endocr Pract. 2003 Sep-Oct;9(5):400-5. doi: 10.4158/EP.9.5.400.
Zotero 插件